Sharma, Sujata
Quinn, David
Melenhorst, J. Joseph
Pruteanu-Malinici, Iulian
Article History
Accepted: 29 December 2020
First Online: 15 January 2021
Compliance with Ethical Standards
:
: SS, DQ, and IP declare no conflicts of interest. JJM is an inventor on several patents issued and pending in the field of CAR T cell therapy for cancer, which are assigned to the University of Pennsylvania. Under the University of Pennsylvania’s policies, JJM may or currently receive royalties from licensing of these patent rights.
: This article does not contain any studies with human or animal subjects performed by any of the authors.